Applicant, as named in the Orange Book
Hong Kong
Next listed expiry: Xenleta on 25 Mar 2033. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Xenleta NDA 211672 lefamulin acetate | 25 Mar 2033 patent |
| Xenleta NDA 211673 lefamulin acetate | 14 Jun 2036 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.